ArticleAntimicrobial agents and chemotherapy2017

Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.

Ching-Chi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.